New developments in antibiotics. Future clinical studies for the National Institute of Allergy and Infectious Diseases.
The classes of anti-infective agents and the numbers in each class that are currently available and in use in the United States are listed, and current activity with respect to discovery and development of new drugs in the most widely used categories is briefly reviewed. Fifteen major areas for future research in the therapy and control of infectious diseases are recommended, and the relative roles for industry, academic and clinical investigators, and government (National Institute of Allergy and Infectious Diseases) in these areas are discussed. There are many problems requiring extensive research and financial support.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000980:Antiplatyhelmintic Agents; D000981:Antiprotozoal Agents; D000998:Antiviral Agents; D002511:Cephalosporins; D010403:Penicillin Resistance; D010406:Penicillins; D012106:Research
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000980:Antiplatyhelmintic Agents; D000981:Antiprotozoal Agents; D000998:Antiviral Agents; D002511:Cephalosporins; D010406:Penicillins